Reducing Cardiovascular Events and End-Organ Damage in Patients with Hypertension: New Considerations

被引:3
|
作者
Harmon, Laura [2 ]
Chilton, Robert J. [1 ]
Spellman, Craig [3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Cardiol, San Antonio, TX 78229 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Div Endocrinol, Midland, TX USA
[4] Texas Tech Univ, Hlth Sci Ctr, Ctr Diabet & Metab Disorders, Midland, TX USA
关键词
hypertension; antihypertensives; blood pressure control; cardiovascular risk; RENIN INHIBITOR ALISKIREN; TYPE-2; DIABETES-MELLITUS; LEFT-VENTRICULAR MASS; BLOOD-PRESSURE; CLINICAL-OUTCOMES; ANTIHYPERTENSIVE EFFICACY; SCIENTIFIC STATEMENT; COMBINATION THERAPY; HEART-FAILURE; BETA-BLOCKERS;
D O I
10.3810/pgm.2011.03.2258
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension treatment should focus on achieving blood pressure (BP) of < 140/90 mm Hg in most patients and < 130/80 mm Hg in patients with diabetes. Lifestyle modifications play a central role in therapy and should be the first line of treatment in all patients. However, long-term lifestyle changes are rarely achieved and pharmacotherapy is required. The selection of an optimal regimen for each patient will depend on comorbid conditions. Most patients will require combination therapy with >= 2 antihypertensive agents to control their BP. The most useful combinations employ drugs from different classes with complementary mechanisms of action, producing additive or synergistic BP reduction with minimal adverse events.
引用
收藏
页码:7 / 17
页数:11
相关论文
共 50 条
  • [1] A new evidence of end-organ damage in the patients with arterial hypertension: Epistaxis?
    Celik, Turgay
    Iyisoy, Atila
    Yuksel, Uygar Cagdas
    Karahatay, Serdar
    Tan, Yalcin
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) : 105 - 107
  • [2] Is epistaxis evidence of end-organ damage in patients with hypertension?
    Neto, JFL
    Fuchs, FD
    Facco, SR
    Gus, M
    Fasolo, L
    Mafessoni, R
    Gleissner, AL
    LARYNGOSCOPE, 1999, 109 (07): : 1111 - 1115
  • [3] Erectile Dysfunction: Indicator of End-Organ Damage in Cardiovascular Patients
    Baumhaekel, Magnus
    Schlimmer, Nils
    Kratz, Mario T.
    Boehm, Michael
    MEDIZINISCHE KLINIK, 2009, 104 (04) : 309 - 313
  • [4] Hypertension, nitric oxide and end-organ damage
    Ishani, A
    Raij, L
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (02): : 237 - 241
  • [5] Isolated office hypertension and end-organ damage
    Ferrara, LA
    Guida, L
    Pasanisi, F
    Celentano, A
    Palmieri, V
    Iannuzzi, R
    Gaeta, I
    Leccia, G
    Crivaro, M
    JOURNAL OF HYPERTENSION, 1997, 15 (09) : 979 - 985
  • [6] Brain injury as end-organ damage in hypertension
    Scuteri, Angelo
    LANCET NEUROLOGY, 2012, 11 (12): : 1015 - 1017
  • [7] Cognitive disorders and dementia - new end-organ damage due to hypertension
    Trenkwalder, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (45) : 1349 - 1349
  • [8] Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension
    Kolman, S. A. M.
    van Sijl, A. M.
    van der Sluijs, F. A.
    van de Ree, M. A.
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (02) : 121 - 125
  • [9] Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension
    S A M Kolman
    A M van Sijl
    F A van der Sluijs
    M A van de Ree
    Journal of Human Hypertension, 2017, 31 : 121 - 125
  • [10] END-ORGAN DAMAGE IN ESSENTIAL-HYPERTENSION IN THE ELDERLY
    KOHARA, K
    HIWADA, K
    JOURNAL OF HUMAN HYPERTENSION, 1995, 9 (09) : 717 - 721